Literature DB >> 11757581

Novel exon 11 skipping mutation in a patient with glycogen storage disease type IIId.

H Sugie1, T Fukuda, M Ito, Y Sugie, T Kojoh, I Nonaka.   

Abstract

We report the molecular genetic abnormalities of a patient with GSD IIId presenting with progressive myopathy and cardiopathy leading to a fatal outcome. We identified two independent deletions including a 4 bp deletion (117-1120) and a 98 bp deletion (1135-1232) in cDNA. Sequencing of the genomic DNA of the corresponding region revealed a 4 bp deletion in exon 10; however, the other 98 bp deletion corresponding to exon 11, which was deleted in cDNA, was present in genomic DNA. We therefore concluded that skipping of exon 11 occurred in the cDNA of the patient. Intron/exon boundary analysis of the skipped exon 11 revealed no mutation in the consensus splice-site sequence. If normal splicing had occurred, a stop codon would have appeared within exon II due to frameshift mutation. The mechanism of exon skipping observed in our patient is as yet unknown, and it is still not clear whether intraexonal mutation of the preceding exon can influence splice-site selection. It is possible that a unique exon skipping occurred, preventing the appearance of a stop codon in our patient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757581     DOI: 10.1023/a:1012459625902

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

Review 1.  RNA processing and human disease.

Authors:  A V Philips; T A Cooper
Journal:  Cell Mol Life Sci       Date:  2000-02       Impact factor: 9.261

2.  Novel mutations in two Japanese cases of glycogen storage disease type IIIa and a review of the literature of the molecular basis of glycogen storage disease type III.

Authors:  T Fukuda; H Sugie; M Ito
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

Review 3.  Glycogen storage disease type III with muscle involvement: reappraisal of phenotypic variability and prognosis.

Authors:  T Momoi; H Sano; C Yamanaka; H Sasaki; H Mikawa
Journal:  Am J Med Genet       Date:  1992-03-01

Review 4.  The regulation of splice-site selection, and its role in human disease.

Authors:  T A Cooper; W Mattox
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

Review 5.  Pre-mRNA splicing.

Authors:  M R Green
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

6.  A novel donor splice site mutation in the glycogen debranching enzyme gene is associated with glycogen storage disease type III.

Authors:  M Okubo; Y Aoyama; T Murase
Journal:  Biochem Biophys Res Commun       Date:  1996-07-16       Impact factor: 3.575

7.  Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect.

Authors:  H Morisaki; T Morisaki; L K Newby; E W Holmes
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III.

Authors:  J H Ding; T de Barsy; B I Brown; R A Coleman; Y T Chen
Journal:  J Pediatr       Date:  1990-01       Impact factor: 4.406

9.  The skipping of constitutive exons in vivo induced by nonsense mutations.

Authors:  H C Dietz; D Valle; C A Francomano; R J Kendzior; R E Pyeritz; G R Cutting
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

10.  Molecular cloning and nucleotide sequence of cDNA encoding human muscle glycogen debranching enzyme.

Authors:  B Z Yang; J H Ding; J J Enghild; Y Bao; Y T Chen
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.